Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/OMI · Entity 6858 | EVP, Chief Commercial Officer | June 03, 2021 | June 07, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date June 03, 2021 · Filed June 07, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 90,650 |
Reported balance
After 2021-06-03 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2021-06-03 · Sale · Disposed 10,392 · Balance 90,650 F1: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. |
| Common StockSEC Table I · non-derivative | Direct | 84,542 |
Reported balance
After 2021-06-03 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2021-06-03 · Tax withholding · Disposed 6,108 · Balance 84,542 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. |
| Common StockSEC Table I · non-derivative | Direct | 71,769 |
Reported balance
After 2021-06-04 transaction · row 3
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 3 · 2021-06-04 · Sale · Disposed 12,746 · Balance 71,769 F1: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021.
F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2021 Filed Jun 7, 2021 20:51 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 12,746 | $42.42 | $540,685.32 |
DisclosureSEC source: 0000075252-21-000120 · edgar.xml · nonDerivative · entry 3 Zacur Mark P · CIK 0001791723 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,769 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:51 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 6,108 | $42.37 | $258,795.96 |
DisclosureSEC source: 0000075252-21-000120 · edgar.xml · nonDerivative · entry 2 Zacur Mark P · CIK 0001791723 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,542 F2 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:51 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 10,392 | $42.23 | $438,854.16 |
DisclosureSEC source: 0000075252-21-000120 · edgar.xml · nonDerivative · entry 1 Zacur Mark P · CIK 0001791723 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,650 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. Read SEC document |
| May 11, 2021 Filed May 13, 2021 12:58 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 5,203 | $33.41 | $173,832.23 |
DisclosureSEC source: 0000075252-21-000101 · edgar.xml · nonDerivative · entry 2 Zacur Mark P · CIK 0001791723 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,042 F2 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| May 11, 2021 Filed May 13, 2021 12:58 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | SaleCommon Stock | 11,210 | $32.47 | $363,988.70 |
DisclosureSEC source: 0000075252-21-000101 · edgar.xml · nonDerivative · entry 1 Zacur Mark P · CIK 0001791723 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,245 F1 · shares: The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 2, 2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:50 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 23,433 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000051 · edgar.xml · nonDerivative · entry 1 Zacur Mark P · CIK 0001791723 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,455 F1 · security: Restricted stock grant which vests one-third per year over three years. F2 · balance_after: Balance includes employee stock purchase plan holdings and/or shares acquired through dividend reinvestment transactions not previously reflected in beneficial ownership total. Read SEC document |
| June 03, 2020 Filed Jun 9, 2020 20:18 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | Tax withholdingCommon Stock | 4,808 | $7.64 | $36,733.12 |
DisclosureSEC source: 0000075252-20-000085 · edgar.xml · nonDerivative · entry 1 Zacur Mark P · CIK 0001791723 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,468 F1 · shares: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock granted to Reporting Person. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:11 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 48,276 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-20-000071 · edgar.xml · nonDerivative · entry 1 Zacur Mark P · CIK 0001791723 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,276 F1 · security: Restricted stock grant which vests one-third per year over three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.